Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 13 Nov 2023
Last Applicant/ Owned by
50 Northern Avenue
Boston
MA
02210
Serial Number
87473439 filed on 02th Jun 2017
Registration Number
5460592 registered on 01st May 2018
in the Principal Register
Correspondent Address
Kelli A. Ovies
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Logo Mark Trademark Information
Pharmaceutical preparations for the treatment of cystic fibrosis
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cystic fibrosis
First Use Date in General
14th Feb 2018
First Use Date in Commerce
14th Feb 2018
Mark Details
Serial Number
No 87473439
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.17.25 -
Other lines, bands or bars
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Nov 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 13th Nov 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 13th Nov 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 12th May 2023 | TEAS SECTION 8 & 15 RECEIVED |
| 01st May 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 01st May 2018 | REGISTERED-PRINCIPAL REGISTER |
| 27th Mar 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 25th Mar 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 06th Mar 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Mar 2018 | STATEMENT OF USE PROCESSING COMPLETE |